Hippocampal avoidance during WBRT reduces risks on NRG Oncology trial
(NRG Oncology) Results from the NRG Oncology clinical study NRG-CC001 concluded that lowering radiotherapy dose to hippocampal stem cells improves cognitive and patient-reported outcomes for patients with brain metastases.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
More News: Brain | Brain Cancers | Cancer | Cancer & Oncology | Neurology | Stem Cell Therapy | Stem Cells | Study